Mannatech, a prominent global player in the realm of health and wellness, is proudly observing its 30th anniversary, celebrating an impressive three decades of spearheading innovation and progress in the domain of nutritional glycobiology. As the world at large begins to fathom the significance of glycans, Mannatech stands as a frontrunner, guiding the path in nutritional glycobiology and reshaping our comprehension of cellular communication and health reinforcement.
Formerly relegated to the periphery as a niche discipline, glycoscience has progressively garnered heightened recognition due to unceasing research and analysis. This shift attained further solidity with the conferment of the 2022 Nobel Prize in Chemistry, which honored advancements in “click chemistry and bioorthogonal chemistry‡.” This accolade underscored the vital role of glycans, often referred to as the absent nutritional component. In this thriving scientific milieu, Mannatech has been at the helm, leveraging the potential of these pivotal molecules through its distinctive glycan technology to formulate an array of state-of-the-art products.
Standing as one of the world’s most scientifically substantiated supplements for cellular communication, Mannatech’s flagship offering, Ambrotose®, resides in a class of its own*. While some may associate Mannatech with premium aloe, a well-known glycans source, the true triumph of the company lies in crafting the sole plant-based glycan complex. This pioneering complex, hailing from four diverse plant sources, touts a composition encompassing ten distinct glycans. This eclectic sourcing has empowered Mannatech to heighten and refine its product repertoire, presenting an unparalleled spectrum of health and wellness solutions tailored to multifarious requirements.
“Our 30-year commemoration isn’t a mere glance back at history but rather a testament to Mannatech’s steadfast dedication to revolutionizing the health and wellness arena,” emphasized Dr. Nugent, Chief Science and Health Officer and globally acclaimed authority in glycan technology. “We recognized the potential of glycans when skepticism was rife, and we take pride in spearheading the movement as the world begins to embrace their transformative potency.”
Since inception, Mannatech has amassed more than 150 patents and presently retains over 95 active patents across major global markets, attesting to Mannatech’s unwavering commitment to scientific exploration and innovation. Rigorous research has culminated in the formulation of a 100% plant-based glycans complex, meticulously designed to augment cell-to-cell interaction and elevate immune support, cognitive well-being, and overall health*. The fruit of this groundbreaking inquiry materializes in a comprehensive line of nutritional, skincare, and weight management offerings, all anchored in the bedrock of glycan technology.
In honor of this momentous milestone, CEO Al Bala, Chief Science and Health Officer Dr. Nugent, President Landen Fredrick, and other Mannatech leaders are embarking on a global celebratory tour, with destinations including Greater China†, South Africa, the United States, Japan, Korea, and Thailand. These gatherings will pay tribute to three decades of accomplishments while casting light on Mannatech’s visionary outlook. The festivities will extend into 2024, with stops scheduled across the United Kingdom, European Union, and Australia.
“As we usher in a new era of exploration and renewed investment in glycan technology, Mannatech remains steadfast in its commitment to innovation, charting new territories, and empowering individuals worldwide to attain optimal health,” affirmed Al Bala, CEO of Mannatech.
President Landen Fredrick added, “Our odyssey across the past 30 years has been extraordinary, yet the prospect that lies ahead elicits even greater excitement. Our allegiance to glycobiology and advanced nutritional science remains resolute, and we eagerly anticipate pushing the boundaries in this domain.”
